Advertisement
Canada markets closed
  • S&P/TSX

    22,259.16
    -31.46 (-0.14%)
     
  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • CAD/USD

    0.7288
    +0.0001 (+0.02%)
     
  • CRUDE OIL

    79.17
    +0.18 (+0.23%)
     
  • Bitcoin CAD

    84,037.01
    -2,209.11 (-2.56%)
     
  • CMC Crypto 200

    1,302.64
    +7.97 (+0.61%)
     
  • GOLD FUTURES

    2,316.00
    -6.30 (-0.27%)
     
  • RUSSELL 2000

    2,055.14
    -9.51 (-0.46%)
     
  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     
  • NASDAQ futures

    18,166.50
    -20.00 (-0.11%)
     
  • VOLATILITY

    13.00
    -0.23 (-1.74%)
     
  • FTSE

    8,354.05
    +40.38 (+0.49%)
     
  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     
  • CAD/EUR

    0.6776
    +0.0005 (+0.07%)
     

Stocks in play: Satellos Bioscience Inc.

Announced today its financial results and operational highlights for the year ended December 31, 2023. For the year ended December 31, 2023, Satellos reported a net loss of $15.9 million ($0.18 loss per share), compared to a net loss $11.3 million ($0.32 loss per share) for the year ended December 31, 2022. Satellos Bioscience Inc. shares T.MSCL are trading down $0.01 at $0.45.

Read: